Nutex Health (NASDAQ:NUTX – Free Report) had its target price lifted by Maxim Group from $100.00 to $225.00 in a research note released on Tuesday morning,Benzinga reports. They currently have a buy rating on the stock.
Separately, Benchmark boosted their target price on shares of Nutex Health from $150.00 to $300.00 and gave the company a “buy” rating in a research report on Thursday, May 15th.
Get Our Latest Stock Report on NUTX
Nutex Health Stock Up 0.6%
Nutex Health (NASDAQ:NUTX – Get Free Report) last released its earnings results on Tuesday, May 13th. The company reported $2.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.15) by $2.71. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%. The company had revenue of $211.79 million for the quarter, compared to the consensus estimate of $81.09 million.
Insider Activity at Nutex Health
In other Nutex Health news, CFO Jon Christian Bates acquired 1,000 shares of the stock in a transaction on Tuesday, April 8th. The shares were purchased at an average price of $81.81 per share, for a total transaction of $81,810.00. Following the completion of the acquisition, the chief financial officer now owns 4,888 shares in the company, valued at approximately $399,887.28. This represents a 25.72% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 38.52% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of NUTX. Topline Capital Management LLC acquired a new position in Nutex Health during the fourth quarter worth $5,690,000. American Century Companies Inc. acquired a new position in Nutex Health during the fourth quarter worth $1,362,000. Ancora Advisors LLC acquired a new position in Nutex Health during the fourth quarter worth $1,334,000. Drive Wealth Management LLC acquired a new position in Nutex Health during the fourth quarter worth $1,122,000. Finally, Essex Investment Management Co. LLC raised its holdings in Nutex Health by 45.4% during the fourth quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company’s stock worth $3,353,000 after buying an additional 33,024 shares during the last quarter. Institutional investors and hedge funds own 5.32% of the company’s stock.
Nutex Health Company Profile
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Recommended Stories
- Five stocks we like better than Nutex Health
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Top 5 Stocks Hedge Funds Are Buying Right Now
- Manufacturing Stocks Investing
- Viking Holdings Posts Strong Q1, Eyes Growth Ahead
- How to find penny stocks to invest and trade
- 2 Reasons Netflix’s 40% Rally Is Far From Over
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.